Explore 3 Stock Ideas & Industry Insights Download Free Report

EvokAI Creative Labs Inc.

Company price
None CAD 0.00(0%)
Last update at 2026-11-05T15:00:16.173790Z
Market Cap
0.87M

Momentum Score

…

EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses. The company also provides EvokAI Simulators, which combine cognitive neuroscience, virtual reality (VR), and AI technologies to assess cognitive performance and spatial perception; EvokAI Movement Disorder Monitor (MDM) Basic, a wireless and real-time monitor that accurately analyzes the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s disease and other movement disorders, such as dystonia, various diseases causing tremors, Tourette´s syndrome, congenial CP, or MS; and EvokAI MDM PRO, which is used to monitor movement disorders in real time for the accurate surgical results. In addition, it offers EvokAI Neurotrainer, which provides brain health solutions for various ages; and EvokAI Medical, which offers mental wellbeing through AI-driven digital solutions. The company is headquartered in Vancouver, Canada. EvokAI Creative Labs Inc. is a subsidiary of Union Acquisition Group, LLC.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.12
Low
0.12
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

EvokAI Creative Labs Inc. has limited public disclosures but identifies as a developer of AI-driven creative tools and services for content production. Long-term growth may be supported by rising adoption of generative AI, successful product commercialization and partnerships with creators or enterprises, which could make the company an avenue for early-stage exposure to the AI content tools market.

Material investment risks include a limited operating and disclosure history, intense competition from larger AI and software firms, execution and commercialization risk, and likely need for additional financing that could dilute existing shareholders.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.12
Dividend Yield
-
Revenue TTM
0.01M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-231.26%
Net Debt
0.01M
ROCE
-594.35%
Diluted EPS TTM
-2.32

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31
Income before tax -17.08M -0.72M -0.09M
Net income -17.08M -0.72M -0.09M
Selling general administrative 1.85M 0.30M 0.01M
Operating income -2.34M -0.72M -0.09M
Interest expense 0.02M 0.00M -
Net interest income -0.02M 0.00M -
Total revenue 0.00M 0.00M 0.00M
Total operating expenses 2.34M 0.72M 0.09M
Total other income expense net -14.72M - -
Net income from continuing ops -17.08M -0.72M -0.09M
Breakdown 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31
Total assets 0.87M 0.00M 0.06M
Total liab 1.16M 0.66M 0.00M
Total stockholder equity -0.28M -0.66M 0.06M
Capital stock 18.76M 3.64M 3.64M
Retained earnings -21.39M -4.30M -3.59M
Cash 0.77M 0.00M 0.01M
Total current liabilities 0.48M 0.66M 0.00M
Net debt 0.01M 0.04M -
Short long term debt 0.11M 0.05M -
Total current assets 0.87M 0.00M 0.06M
Net receivables 0.03M 0.00M 0.00M
Long term debt 0.68M - -
Accounts payable - 0.16M 0.01M
Non current assets total 0.00M 0.00M 0.00M
Breakdown 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31
Net borrowings -0.11M 0.00M 0.00M
Total cash from financing activities -0.11M 0.00M 0.00M
Net income -17.08M -0.72M -0.09M
Change in cash 0.77M -0.00M -0.09M
Begin period cash flow 0.00M 0.01M 0.13M
End period cash flow 0.77M 0.00M 0.04M
Total cash from operating activities -2.53M -0.00M -0.09M
Issuance of capital stock - 0.24M 0.00M
Change to account receivables -0.06M 0.00M -
Capital expenditures 0.00M 0.00M 0.00M
Change in working capital -0.80M 0.71M -0.00M
Stock based compensation 0.61M 0.00M -
Other non cash items 2.08M 0.00M -
Free cash flow -2.53M -0.00M -0.09M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
NURS
Hydreight Technologies Inc
0.09
3.20%
2.90 406.00 25.91 7.85 20.38 109.02
ADK
Diagnos Inc
0.01
1.41%
0.36 - 10.00 411.24 18.74 -6.16
NXG
NexgenRX Inc.
-
-%
0.66 39.00 32.68 1.55 4.64 7.84
PTEC
Principal Technologies Inc
-
-%
0.32 - - 62.75 355.42 -0.81

Profile*

EvokAI Creative Labs Inc.

EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses. The company also provides EvokAI Simulators, which combine cognitive neuroscience, virtual reality (VR), and AI technologies to assess cognitive performance and spatial perception; EvokAI Movement Disorder Monitor (MDM) Basic, a wireless and real-time monitor that accurately analyzes the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s disease and other movement disorders, such as dystonia, various diseases causing tremors, Tourette´s syndrome, congenial CP, or MS; and EvokAI MDM PRO, which is used to monitor movement disorders in real time for the accurate surgical results. In addition, it offers EvokAI Neurotrainer, which provides brain health solutions for various ages; and EvokAI Medical, which offers mental wellbeing through AI-driven digital solutions. The company is headquartered in Vancouver, Canada. EvokAI Creative Labs Inc. is a subsidiary of Union Acquisition Group, LLC.

609 Granville Street, Vancouver, BC, Canada, V7Y 1C3

Name Title Year Born
Mr. Alejandro Antalich CEO & Director 1974
Mr. Scott Edwin Ackerman CFO, Corporate Secretary & Director 1967
Mr. Rauno Jokelainen Operations Manager NA
Dr. Georg Meissner Executive Vice President of Digital Health Research & Technology NA
Ms. Tuula Palmen Chief Business Officer NA
Mr. Hans J. Lauterbach President of Europe, Asia Pacific & Middle East NA
Mr. Alejandro Antalich CEO & Director 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…